vs
Side-by-side financial comparison of IRIDEX CORP (IRIX) and MicroAlgo Inc. (MLGO). Click either name above to swap in a different company.
MicroAlgo Inc. is the larger business by last-quarter revenue ($26.3M vs $14.7M, roughly 1.8× IRIDEX CORP). On growth, MicroAlgo Inc. posted the faster year-over-year revenue change (-35.5% vs -69.7%).
IRIDEX Corporation is a global medical technology company that designs, manufactures and distributes advanced laser-based medical devices, primarily serving the ophthalmology and aesthetic medicine sectors. It supplies products to healthcare providers, clinics and medical facilities across North America, Europe, Asia Pacific and other regions, delivering minimally invasive solutions for eye disease treatment and cosmetic procedures.
MicroAlgo Inc. is a technology enterprise specializing in custom algorithm optimization solutions. It mainly serves clients across smart city management, industrial internet, and e-commerce sectors, helping enterprises improve operational efficiency, reduce operating costs, and optimize data processing performance for real business scenarios.
IRIX vs MLGO — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2025
| Metric | ||
|---|---|---|
| Revenue | $14.7M | $26.3M |
| Net Profit | — | — |
| Gross Margin | 37.2% | — |
| Operating Margin | — | — |
| Net Margin | — | — |
| Revenue YoY | -69.7% | -35.5% |
| Net Profit YoY | — | — |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $14.7M | — | ||
| Q3 25 | $12.5M | — | ||
| Q2 25 | $13.6M | $26.3M | ||
| Q1 25 | $11.9M | — | ||
| Q4 24 | $12.7M | $34.6M | ||
| Q3 24 | $11.6M | — | ||
| Q2 24 | $12.6M | $40.8M | ||
| Q1 24 | $11.8M | — |
| Q4 25 | — | — | ||
| Q3 25 | $-1.6M | — | ||
| Q2 25 | $-994.0K | — | ||
| Q1 25 | $-1.7M | — | ||
| Q4 24 | $-834.0K | $4.2M | ||
| Q3 24 | $-1.9M | — | ||
| Q2 24 | $-2.7M | — | ||
| Q1 24 | $-3.5M | — |
| Q4 25 | 37.2% | — | ||
| Q3 25 | 32.1% | — | ||
| Q2 25 | 34.5% | — | ||
| Q1 25 | 42.5% | — | ||
| Q4 24 | 44.0% | 26.4% | ||
| Q3 24 | 37.3% | — | ||
| Q2 24 | 40.7% | — | ||
| Q1 24 | 37.9% | — |
| Q4 25 | — | — | ||
| Q3 25 | -11.3% | — | ||
| Q2 25 | -6.9% | — | ||
| Q1 25 | -1.7% | — | ||
| Q4 24 | -3.9% | 7.0% | ||
| Q3 24 | -16.1% | — | ||
| Q2 24 | -20.9% | — | ||
| Q1 24 | -28.0% | — |
| Q4 25 | — | — | ||
| Q3 25 | -12.6% | — | ||
| Q2 25 | -7.3% | — | ||
| Q1 25 | -14.2% | — | ||
| Q4 24 | -6.6% | 12.1% | ||
| Q3 24 | -16.7% | — | ||
| Q2 24 | -21.2% | — | ||
| Q1 24 | -29.5% | — |
| Q4 25 | — | — | ||
| Q3 25 | $-0.09 | — | ||
| Q2 25 | $-0.06 | — | ||
| Q1 25 | $-0.10 | — | ||
| Q4 24 | $-0.05 | $0.56 | ||
| Q3 24 | $-0.12 | — | ||
| Q2 24 | $-0.16 | — | ||
| Q1 24 | $-0.21 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $6.0M | $319.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $317.6M |
| Total Assets | $29.2M | $330.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $6.0M | — | ||
| Q3 25 | $5.6M | — | ||
| Q2 25 | $6.8M | $319.4M | ||
| Q1 25 | $7.2M | — | ||
| Q4 24 | $2.4M | $164.9M | ||
| Q3 24 | $3.9M | — | ||
| Q2 24 | $4.1M | $66.7M | ||
| Q1 24 | $5.4M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.0M | — | ||
| Q3 24 | $1.4M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | $4.7M | — | ||
| Q2 25 | $6.1M | $317.6M | ||
| Q1 25 | $852.0K | — | ||
| Q4 24 | $2.1M | $144.9M | ||
| Q3 24 | $2.6M | — | ||
| Q2 24 | $4.2M | $76.0M | ||
| Q1 24 | $6.5M | — |
| Q4 25 | $29.2M | — | ||
| Q3 25 | $28.4M | — | ||
| Q2 25 | $31.6M | $330.8M | ||
| Q1 25 | $34.2M | — | ||
| Q4 24 | $29.1M | $176.3M | ||
| Q3 24 | $30.2M | — | ||
| Q2 24 | $31.2M | $107.6M | ||
| Q1 24 | $34.1M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.48× | — | ||
| Q3 24 | 0.53× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.